Companies Dominating the Non-Coding RNA Assays Landscape
- Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Springer Nature Limited
- Applied Microarrays Inc.
- C D Genomics
- RELX Group
- MilliporeSigma
- QIAGEN
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf SE
Browse Key Market Insights with Data Illustration:
In the News
-
QIAGEN introduced QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, to speed up the identification of DNA variants and RNA sequencing in low input samples. Further, the new solutions are based on enhanced chemistry that reduces the time required for library construction of DNA samples and establishes new criteria for processing materials in order to identify their nucleic acid sequences.
-
C D Genomics launched Whole Exome Sequencing, to extend its sequencing portfolio. Further, DNA sections known as exomes play a direct role in protein coding, and this approach is mostly employed to discover and investigate mutations in coding and UTR regions.
